217 related articles for article (PubMed ID: 32580046)
1. Anti-IL-12/23 p40 antibody attenuates chronic graft-versus-host disease with lupus nephritis via inhibiting Tfh cell in mice.
Gao Y; Zeng Y; Xue W; Chen Y; Li Q; Bian Z; Tang L; Tang T; Chen C; Gao X; Guo W
Biomed Pharmacother; 2020 Sep; 129():110396. PubMed ID: 32580046
[TBL] [Abstract][Full Text] [Related]
2. Concomitant use of interleukin-2 and tacrolimus suppresses follicular helper T cell proportion and exerts therapeutic effect against lupus nephritis in systemic lupus erythematosus-like chronic graft versus host disease.
Nasa Y; Satake A; Tsuji R; Saito R; Tsubokura Y; Yoshimura H; Ito T
Front Immunol; 2024; 15():1326066. PubMed ID: 38665907
[TBL] [Abstract][Full Text] [Related]
3. Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice.
Lin M; Huang L; Huang J; Yu J; Yang X; Yang J
J Autoimmun; 2024 May; 145():103198. PubMed ID: 38428341
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
5. Ustekinumab Inhibits T Follicular Helper Cell Differentiation in Patients With Crohn's Disease.
Globig AM; Sommer NP; Wild K; Schardey J; Zoldan K; Thomann AK; Schulte LA; Schreiner R; Reindl W; Klaus J; Schempp CM; Hofmann M; Thimme R; Boettler T; Hasselblatt P
Cell Mol Gastroenterol Hepatol; 2021; 11(1):1-12. PubMed ID: 32679193
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells.
Duan X; Shen C; Zhang X; Wu L; Chen J; Ma B; Wang Q; Sun P; Lan Y; Su C
Int Immunopharmacol; 2020 Mar; 80():106239. PubMed ID: 32007709
[TBL] [Abstract][Full Text] [Related]
7. Anti-IL-12/23 p40 antibody attenuates experimental chronic graft-versus-host disease via suppression of IFN-γ/IL-17-producing cells.
Okamoto S; Fujiwara H; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Yoshimura A; Tanimoto M; Maeda Y
J Immunol; 2015 Feb; 194(3):1357-63. PubMed ID: 25527789
[TBL] [Abstract][Full Text] [Related]
8. A truncated IL-12rβ1 receptor ameliorates chronic graft-versus-host disease-induced lupus nephritis by inhibiting Th1 and Th17 cells.
Wang C; Guo W; Cai D; Wang X; Yu D; Gao X; Yao W
Int Immunopharmacol; 2015 Dec; 29(2):544-551. PubMed ID: 26474696
[TBL] [Abstract][Full Text] [Related]
9. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney.
Zhang JL; Sun DJ; Hou CM; Wei YL; Li XY; Yu ZY; Feng JN; Shen BF; Li Y; Xiao H
Transpl Immunol; 2010 Oct; 24(1):17-25. PubMed ID: 20850528
[TBL] [Abstract][Full Text] [Related]
10. PD-L1- and IL-4-expressing basophils promote pathogenic accumulation of T follicular helper cells in lupus.
Tchen J; Simon Q; Chapart L; Thaminy MK; Vibhushan S; Saveanu L; Lamri Y; Saidoune F; Pacreau E; Pellefigues C; Bex-Coudrat J; Karasuyama H; Miyake K; Hidalgo J; Fallon PG; Papo T; Blank U; Benhamou M; Hanouna G; Sacre K; Daugas E; Charles N
Nat Commun; 2024 Apr; 15(1):3389. PubMed ID: 38649353
[TBL] [Abstract][Full Text] [Related]
11. Conversion of T Follicular Helper Cells to T Follicular Regulatory Cells by Interleukin-2 Through Transcriptional Regulation in Systemic Lupus Erythematosus.
Hao H; Nakayamada S; Yamagata K; Ohkubo N; Iwata S; Inoue Y; Zhang M; Zhang T; Kanda Satoh Y; Shan Y; Otsuka T; Tanaka Y
Arthritis Rheumatol; 2021 Jan; 73(1):132-142. PubMed ID: 32720470
[TBL] [Abstract][Full Text] [Related]
12. Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.
Wu Y; Bastian D; Schutt S; Nguyen H; Fu J; Heinrichs J; Xia C; Yu XZ
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1195-204. PubMed ID: 25846718
[TBL] [Abstract][Full Text] [Related]
13. Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus.
Satoh-Kanda Y; Nakayamada S; Kubo S; Yamagata K; Nawata A; Tanaka H; Kosaka S; Kanda R; Yu S; Fujita Y; Sonomoto K; Tanaka Y
RMD Open; 2024 Jun; 10(2):. PubMed ID: 38871479
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of receptor interacting protein kinase-1 (RIPK1) in the treatment of murine lupus.
Peng L; Wang P; Xu X; Chen D; Xu F; Yang F; Yang S; Xia H; Liu ZH; Qin W
Lupus Sci Med; 2024 Jun; 11(1):. PubMed ID: 38906550
[TBL] [Abstract][Full Text] [Related]
15. Sirtuin 1 overexpression contributes to the expansion of follicular helper T cells in systemic lupus erythematosus and may serve as an accessible therapeutic target.
He L; Liao W; Wang X; Wang L; Liang Q; Jiang L; Yi W; Luo S; Liu Y; Qiu X; Li Y; Liu J; Wu H; Zhao M; Long H; Lu Q
Rheumatology (Oxford); 2024 May; 63(6):1699-1709. PubMed ID: 37665721
[TBL] [Abstract][Full Text] [Related]
16. Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.
Foster AD; Haas M; Puliaeva I; Soloviova K; Puliaev R; Via CS
Clin Immunol; 2010 Jul; 136(1):61-73. PubMed ID: 20451460
[TBL] [Abstract][Full Text] [Related]
17. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
18. Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB/NZW) F1 lupus-prone mice.
Moon JS; Mun CH; Kim JH; Cho JY; Park SD; Park TY; Shin JS; Ho CC; Park YB; Ghosh S; Bothwell ALM; Lee SW; Lee SK
Kidney Int; 2018 May; 93(5):1118-1130. PubMed ID: 29409726
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease.
Kuroiwa T; Iwasaki T; Imado T; Sekiguchi M; Fujimoto J; Sano H
Arthritis Res Ther; 2006; 8(4):R123. PubMed ID: 16859527
[TBL] [Abstract][Full Text] [Related]
20. Type I Interferon-Activated STAT4 Regulation of Follicular Helper T Cell-Dependent Cytokine and Immunoglobulin Production in Lupus.
Dong X; Antao OQ; Song W; Sanchez GM; Zembrzuski K; Koumpouras F; Lemenze A; Craft J; Weinstein JS
Arthritis Rheumatol; 2021 Mar; 73(3):478-489. PubMed ID: 33512094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
